Imuraya Group Company Limited operates within the Candy & other confectionery products sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Imuraya Group Company Limited with three other
bakery and confectionary companies in Asia:
Morinaga & Co Ltd
sales of 199.48 billion Japanese Yen [US$1.78 billion]
of which 95%
was Food Products),
Nakamuraya Co., Ltd.
(41.90 billion Japanese Yen [US$374.18 million]
of which 71%
was Confectionery Business), and
GlaxoSmithKline Consumer Healthcare Limited
based in India
(39.86 billion Indian Rupees [US$620.29 million]
of which 100%
During the year ended March of 2017, sales at
Imuraya Group Company Limited were ¥42.00 billion (US$375.04 million).
increase of 8.7%
versus 2016, when the company's sales were ¥38.64 billion.
This was the fifth consecutive year of sales increases at Imuraya Group Company Limited
(and since 2012, sales have increased a total of 29%).
Sales of Distribution Business saw an increase
8.9% in 2017, from
¥33.85 billion to ¥36.87 billion.